Immunosuppressive drugs. I

December 1970
British Medical Journal;12/12/1970, Vol. 4 Issue 5736, p663
Academic Journal
No abstract available.


Related Articles

  • Immunosuppressive and calcimimetic drug-drug interactions. Izzedine, Hassane; Launay-Vacher, Vincent; Karie, Svetlana; Deray, Gilbert // Kidney International;Oct2005, Vol. 68 Issue 4, p1903 

    Presents a letter to the editor about the immunosuppressive and calcimimetic drug-drug interactions.

  • Managing panuveitis without steroids can be difficult. Cooney, Michael J.; Jaffe, Glenn // Ophthalmology Times;09/01/99, Vol. 24 Issue 17, p18 

    Discusses the use of immunosuppressive agents as an alternative to the management of panuveitis without steroids. Information on the classes of immunosuppressive agents; Reminder after the administration of immunosuppressive drugs.

  • Immunosuppressive drugs: Beyond glucocorticoids. Pressler, Barrak // Veterinary Medicine;Aug2010, Vol. 105 Issue 8, p364 

    The article reviews the article "Immunosuppressive Drugs: Beyong Glucocorticoids," by Barrack Pressler.

  • Investigation on correlation of genotype combinations of VEGF-1154 G/A and -2578 C/A genotypes with suppression of VEGF production after treatment with immunosuppressive drugs. Mohammadi, Mojgan; Ollier, W. E. R.; Hutchinson, I. V. // Journal of Medical Genetics;Sep2005, Vol. 42, pS93 

    Presents an abstract of the article "Investigation on Correlation of Genotype Combinations of VEGF-1154 G/A and -2578 C/A Genotypes With Suppression of VEGF Production After Treatment With Immunosuppressive Drugs," by Mojgan Mohammadi, W. E. R. Ollier, and I. V. Hutchinson.

  • Myelodysplastic syndrome with signs of auto-immune disease in a patient with renal allograft. Förster, E.; Birnbacher, R.; Mann, G.; Balzar, E.; Radaszkiewicz, T.; Urbanek, R.; Förster, E // European Journal of Pediatrics;1998, Vol. 157 Issue 4, p351 

    Presents a medical case of a patient with myelodysplastic syndrome (MDS). History of the patient; Description of immunosuppressed individuals; Side effects of immunosuppressive drugs on MDS patients.

  • Where do we stand on drug treatment for ulcerative colitis? Korelitz, Burton I.; Korelitz, B I // Annals of Internal Medicine;4/15/92, Vol. 116 Issue 8, p692 

    Editorial. Enumerates and discusses the effectiveness of several drug treatments for ulcerative colitis. Sulfasalazine; Immunosuppressive drugs; Olsalazine.

  • Cyclosporine: a new immunosuppressive agent for organ transplantation. Cohen, David J.; Loertscher, Rolf; Rubin, Mario F.; Tilney, Nicholas L.; Carpenter, Charles B.; Strom, Terry B.; Cohen, D J; Loertscher, R; Rubin, M F; Tilney, N L; Carpenter, C B; Strom, T B // Annals of Internal Medicine;Nov84, Vol. 101 Issue 5, p667 

    Cyclosporine, a cyclic endecapeptide of fungal origin, has recently been released for use in clinical transplantation. Trials in kidney, heart, liver and bone marrow recipients were encouraging: 1-year graft survival rates were 70% to 80% for kidney and heart recipients, and 60% to 65% for liver...

  • IMMUNOSUPPRESSANTS.  // Davis's Drug Guide for Nurses, 9th edition;2005, pC58 

    Provides pharmacologic information on immunosuppressants. Pharmacokinetics; Side effects of the drug; Drug interactions; Evaluation of effectiveness.

  • mycophenolate.  // Davis's Drug Guide for Nurses, 9th edition;2005, p717 

    Presents information on mycophenolate, an immunosuppressant. Pharmacokinetics; Adverse reactions and side effects; Drug interactions; Required dosage of the drug for adults.

  • Reply from the Authors. Ballermann, Barbara J. // Kidney International;Oct2005, Vol. 68 Issue 4, p1902 

    Presents a letter to the editor in response to the article about the immunosuppressive and calcimimetic drug-drug interactions.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics